{{Rsnum
|rsid=3138053
|Gene=NFKBIA
|Chromosome=14
|position=35405648
|Orientation=minus
|GMAF=0.2277
|Gene_s=NFKBIA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 50.4 | 39.8 | 9.7
| HCB | 73.7 | 22.6 | 3.6
| JPT | 72.6 | 23.9 | 3.5
| YRI | 69.9 | 26.7 | 3.4
| ASW | 43.6 | 47.3 | 9.1
| CHB | 73.7 | 22.6 | 3.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 47.5 | 43.6 | 8.9
| LWK | 68.2 | 27.1 | 4.7
| MEX | 58.9 | 33.9 | 7.1
| MKK | 66.5 | 31.6 | 1.9
| TSI | 51.0 | 36.0 | 13.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24368589
|Title=Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis
}}

{{PMID Auto
|PMID=17463416
|Title=IkappaB genetic polymorphisms and invasive pneumococcal disease.
}}

{{PMID Auto
|PMID=19500386
|Title=Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer.
|OA=1
}}

{{PMID Auto
|PMID=19797428
|Title=IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
|OA=1
}}

{{PMID Auto
|PMID=21274447
|Title=Genetic polymorphisms and posttraumatic complications.
|OA=1
}}

{{PMID Auto
|PMID=23487427
|Title=Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia.
}}

{{PMID Auto
|PMID=23996241
|Title=Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer
}}

{{PMID Auto
|PMID=25223483
|Title=Effect of functional nuclear factor kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma
}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}